Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Waltham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
CRESCENT BIOPHARMA, INC. has filed 656 SEC EDGAR filings since 10 Jul 2003

SEC filing history

Showing 576-600 of 652 matching filings.

Per page
25
Current page
24
4

FORM 4 SUBMISSION

Filing date
17 Dec 2014
Reporting date
15 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36177

FORM 8-K

Filing date
31 Oct 2014
Reporting date
31 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36177

FORM 8-K

Filing date
26 Sep 2014
Reporting date
26 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36177

FORM 8-K

Filing date
31 Jul 2014
Reporting date
31 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36177

FORM 8-K

Filing date
28 Jul 2014
Reporting date
23 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Jul 2014
Reporting date
08 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
10 Jul 2014
Reporting date
08 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36177

FORM 8-K

Filing date
10 Jul 2014
Reporting date
08 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Jun 2014
Reporting date
18 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Jun 2014
Reporting date
12 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36177

FORM 8-K

Filing date
08 May 2014
Reporting date
08 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36177

FORM 8-K

Filing date
04 Apr 2014
Reporting date
31 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Apr 2014
Reporting date
03 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Apr 2014
Reporting date
31 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
01 Apr 2014
Reporting date
31 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-36177

FORM 10-K

Filing date
31 Mar 2014
Reporting date
31 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36177

FORM 8-K

Filing date
14 Mar 2014
Reporting date
10 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87811

DISCLOSURE DOCUMENT

Filing date
10 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-87811

GLYCOMIMETICS, INC.

Filing date
23 Jan 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Jan 2014
Reporting date
15 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Jan 2014
Reporting date
15 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Jan 2014
Reporting date
15 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .